ArticleToxins2023

Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study.

Shigeomi Iimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.